Brock University Professor of Health Sciences Newman Sze, who is the Canada Research Chair in Mechanisms of Health and Disease, and his international team have discovered a groundbreaking immunotherapy method that could potentially add years to healthy aging.
A Brock-led international research team has discovered a groundbreaking immunotherapy method that could potentially add years to healthy aging.
The research, published in the journal EMBO Molecular Medicine, introduces an innovative method to address health issues arising from poor lifestyle choices, which can cause damage to biomolecules and contribute to the development of diseases later in life.
Professor of Health Sciences Newman Sze and his team developed an approach that involves directing the immune system to clear out accumulated proteins damaged by inactive lifestyles, unhealthy diets, various stresses and genetic factors, root causes of aging and age-related diseases.
“Age-related chronic diseases are a major health-care burden,” says Sze, the Canada Research Chair in Mechanisms of Health and Disease. “We therefore developed a first-of-its-kind monoclonal antibody drug that harnesses the immune system to target and remove these abnormal proteins, providing an effective treatment for age-related health problems.”
As time passes, environmental stresses and physiological conditions cause biomolecular damages in tissues. One of these changes, called isoDGR, triggers chronic inflammation in the body and leads to tissue degeneration.
Uncontrolled chronic inflammation, in turn, can lead to conditions such as cardiovascular disease, cancer, Type 2 diabetes, arthritis and Alzheimer’s disease.
While the accumulation of isoDGR has been identified as a ‘molecular clock’ of aging, the new research paper says potential benefits of targeting these structures with specific immunotherapies remain largely unknown.
Sze and his team created monoclonal antibodies called isoDGR-mAb. These lab-engineered proteins are designed to boost the immune system’s ability to attack unhealthy cells or abnormal molecules. Such immunotherapies are already being used to treat various cancers, autoimmune disorders and infectious diseases.
Using animal models, the team found that these lab-engineered molecules stimulated the immune system to clear out the proteins in tissues that had been damaged by isoDGR. Treatment with isoDGR-mAb not only doubled lifespan but also preserved behaviour and co-ordination functions and reduced pro-inflammatory cytokine levels in the circulation and body tissues.
Sze says the team’s findings could lead to the development of immunotherapy-based interventions to extend the healthy lifespan of humans.
“The existing treatments for age-related diseases primarily address symptoms,” says Sze. “Our pioneering mAb, uniquely focused on targeting the root causes of chronic diseases, is anticipated to substantially extend human health span.”
As Canada Research Chair, Sze studies diseases that occur as people age, specifically diseases related to the brain and the blood vessels becoming damaged. His lab has developed new research methods that investigate how body tissues deteriorate over time, and created new drugs to guide the immune system to eliminate abnormal biomolecules.
This latest paper, “Immunotherapy targeting isoDGR-protein damage extends lifespan in a mouse model of protein deamidation,” involved researchers from Brock as well as universities in Singapore, China, New Zealand and the United Kingdom.
The team’s Brock researchers include Health Sciences Professors Deborah O’Leary and Evangelia Tsiani, Health Sciences Associate Professors Adam MacNeil and Rebecca MacPherson, and graduate students Ranjith Iyappan, Evelin Melekh and SoFong Cam Ngan.
Original Article: Brock-led immunotherapy research shows potential to extend healthy lifespan of humans
More from: Brock University | Nanyang Technological University | Westlake University | University of Otago | Queen Mary University of London | Newcastle University
The Latest Updates from Bing News
Go deeper with Bing News on:
Monoclonal antibody drug
- EMA committee adopts positive opinion for Biogen’s Tofidence, a biosimilar monoclonal antibody referencing Roactemra
EMA committee adopts positive opinion for Biogen’s Tofidence, a biosimilar monoclonal antibody referencing Roactemra: Cambridge, Massachusetts Saturday, April 27, 2024, 17:00 Hr ...
- Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows
One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country's six-month malaria season, according to the results ...
- Breakthrough Vaccine Shows High Protection Against Drug-Resistant Superbug in Mice
Scientists have developed a vaccine against a notorious drug-resistant superbug, targeting molecules on its surface that are also found on other bacteria and fungi.
- Monoclonal antibody offers strong malaria protection in children
Today in the New England Journal of Medicine a study demonstrates that a single subcutaneous (just-under-the-skin) injection of an experimental malaria monoclonal antibody offered up to 77% protection ...
- Scientists learn from caterpillars how to create self-assembling capsules for drug delivery
Self-assembling molecules that spontaneously organize themselves to form complex structures are common in nature. For example, the tough outer layer of insects, called the cuticle, is rich in proteins ...
Go deeper with Bing News on:
Healthy aging
- Georgia to host development summit; climate change, aging on agenda
The Asian Development Bank’s annual summit will be in Tbilisi, with finance ministers from China, Japan and South Korea in attendance ...
- 8 ways to keep your brain healthy, from doing crossword puzzles to limiting alcohol
Brain health is something people of all ages should be thinking about, say experts. Here are some smart steps you can take to do just that.
- Healthy Aging Martha’s Vineyard: May 2024
By Jamie Loschen As the new associate director of Healthy Aging Martha’, I am thrilled to share with you some exciting updates and initiatives we’ve been working on over the past two months. One of ...
- Silver hair, silver dollars: Wyoming's aging population means big spending for the state
The graying of America, and Wyomingites, need long-term care in the coming decades. How will the state deal with the cost?
- Research highlights role of faith spaces in supporting healthy aging
A team of researchers from The University of Manchester has spent the last 18 months examining how faith spaces in Greater Manchester support different groups of older people within their communities.